Filing Details
- Accession Number:
- 0001127602-20-015882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 10:48:16
- Reporting Period:
- 2020-05-07
- Accepted Time:
- 2020-05-08 10:48:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650274 | Ross David Smith | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-07 | 1,884 | $150.00 | 18,591 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.